4 results match your criteria: "Cedars-Sinai Bone Center of Excellence[Affiliation]"
A reference case for economic evaluations in osteoarthritis: an expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
Semin Arthritis Rheum
December 2014
Department of Public Health, Epidemiology and Health Economics, University of Liege, Liege, Belgium.
Background: General recommendations for a reference case for economic studies in rheumatic diseases were published in 2002 in an initiative to improve the comparability of cost-effectiveness studies in the field. Since then, economic evaluations in osteoarthritis (OA) continue to show considerable heterogeneity in methodological approach.
Objectives: To develop a reference case specific for economic studies in OA, including the standard optimal care, with which to judge new pharmacologic and non-pharmacologic interventions.
Osteoporosis.
Rheum Dis Clin North Am
August 2011
Cedars-Sinai Bone Center of Excellence, 8641 Wilshire Boulevard, Suite 301, Los Angeles, CA 90211, USA.
Teriparitide update.
Rheum Dis Clin North Am
August 2011
Cedars-Sinai Bone Center of Excellence, 8641 Wilshire Boulevard, Suite 301, Beverly Hills, CA 90211, USA.
Teriparitide (TPD) is a novel anabolic agent that stimulates bone formation. TPD reduces risk of vertebral and nonvertebral fracture. Due to its positive effects on bone formation, many new uses of TPD are being explored.
View Article and Find Full Text PDFDefining zoledronate's duration of action and optimal dosing interval for an effective therapy.
Curr Osteoporos Rep
March 2011
Medical Director Cedars-Sinai Bone Center of Excellence, David Geffen School of Medicine UCLA, 8641 Wilshire Boulevard, Suite 301, Beverly Hills, CA 90211, USA.